Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Peptide And Anticoagulant Drugs Market from 2024 to 2025?
The market for peptide and anticoagulant drugs has experienced significant expansion in the past few years. The market size is projected to increase from $1.41 billion in 2024 to $1.56 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.6%. The historical expansion is due to factors such as growing healthcare expenditures, increased medical investments, liberalization of the market, a surge in the global count of infection cases, and a higher frequency of genetic disorders.
What Is the Projected Market Size of the Peptide And Anticoagulant Drugs Market?
In the coming years, rapid expansion is anticipated in the peptide and anticoagulant drugs market, with a projected increase to $2.30 billion by 2029, marking a compound annual growth rate (CAGR) of 10.3%. Factors contributing to this expected growth in the forecast period include the increasing incidence of chronic diseases, an aging population, a surge in cancer cases, the expansion of emerging markets, and the escalating impact of cardiovascular diseases. The forecast period also anticipates major trends such as advancements in biotechnology, technological progression in drug delivery, enhanced diagnostic techniques, pharmacology advancements, and the production of anticoagulant products.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21252&type=smp
Who are the Major Competitors in the Peptide And Anticoagulant Drugs Market Outlook?
Major companies operating in the peptide and anticoagulant drugs market are Pfizer Inc., Merck & Co. Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Sanofi S.A., Abbott Laboratories, Novartis AG, Novo Nordisk A/S, Viatris Inc., Baxter International Inc., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Bachem Holding AG, Bharat Serums and Vaccines Limited, Wockhardt Limited, AmbioPharm Inc., MITS Healthcare Private Limited, Siddha Pharmacy, Circle Pharma Inc., Tenwel Pharmaceuticals Pvt. Ltd.
What Is Fueling Growth in the Peptide And Anticoagulant Drugs Market?
The growth of the peptide and anticoagulant drugs market is expected to be spurred by the increasing prevalence of chronic illnesses. Chronic diseases are prolonged health conditions that last for many years or even indefinitely. This surge in chronic diseases is due to factors like ageing populations, unhealthy habits, and a higher presence of risk factors like obesity, hypertension, and diabetes. Peptides and anticoagulants are employed in the treatment of chronic conditions like heart diseases, thrombosis, and stroke, as they prevent clotting and target specific disease processes to improve patient outcomes. For instance, reports from the US-based government entity, Centers for Disease Control and Prevention, showed that the number of deaths caused by heart disease and cancer rose from 605,213 in 2021 to 695,547 in 2022. Consequently, as chronic diseases become more prevalent, so does the growth of the peptide and anticoagulant drugs market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21252&type=smp
Which Peptide And Anticoagulant Drugs Market Segments Are Growing the Fastest?
The peptide and anticoagulant drugs market covered in this report is segmented –
1) By Type: Hormonal, Antibiotic, Ace Inhibitor, Antifungal, Other Types
2) By Route Of Administration: Oral, Injectable, Other Routes Of Administration
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
4) By Application: Infectious Diseases, Gynecology, Cancer, Diabetes, Cardiology, Osteoporosis, Other Applications
5) By End-users: Hospitals, Specialty Clinics, Homecare, Other End-users
Subsegments:
1) By Hormonal: Peptide Hormones, Steroid Hormones, Thyroid Hormones, Other Hormones
2) By Antibiotic: Beta-Lactams, Macrolides, Tetracyclines, Fluoroquinolones, Other Antibiotics
3) By ACE Inhibitor: Captopril, Enalapril, Lisinopril, Ramipril, Other ACE Inhibitors
4) By Antifungal: Azoles, Echinocandins, Polyenes, Allylamines, Other Antifungals
5) By Other Types: Immunosuppressants, Antineoplastic Agents, Cardiovascular Drugs, Other Peptide And Anticoagulant Drugs
Which Industry Trends Are Shaping the Future of the Peptide And Anticoagulant Drugs Market?
Major firms in the peptide and anticoagulant drugs market are focusing on enhancing anticoagulant therapies like oral anticoagulants. The goal is to improve their effectiveness, boost patient adherence, and reduce the chances of bleeding complications. Oral anticoagulants are medications consumed orally to prevent blood clots by suppressing the blood’s clotting factors. For example, in April 2024, Cadrenal Therapeutics Inc., a pharmaceutical company from the U.S, earned the Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA) for their late-stage oral anticoagulant, tecarfarin. This medication is intended to be an innovative, reversible blood thinner that decreases heart attack, stroke, and mortality risks related to blood clots in patients with uncommon cardiovascular conditions. Specifically, the ODD is for the prevention of thromboembolism and thrombosis in patients who have mechanical circulatory support devices implanted, like left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), ventricular assist devices (VADs), biventricular assist devices, and total artificial hearts.
Access The Full Report Here:
Which Countries Are Leading the Peptide And Anticoagulant Drugs Market?
North America was the largest region in the peptide and anticoagulant drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide and anticoagulant drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21252
This Report Delivers Insight On:
1. How big is the peptide and anticoagulant drugs market, and how is it changing globally?
2. Who are the major companies in the peptide and anticoagulant drugs market, and how are they performing?
3. What are the key opportunities and risks in the peptide and anticoagulant drugs market right now?
4. Which products or customer segments are growing the most in the peptide and anticoagulant drugs market?
5. What factors are helping or slowing down the growth of the peptide and anticoagulant drugs market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model